Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients
<p><b>BACKGROUND</b>- Type 2 diabetes (T2D) and obesity are associated with non-alcoholic fatty liver disease, cardiomyopathy and cardiovascular mortality. Both conditions showed stronger links between ectopic and visceral fat deposition and increased cardio-metabolic risk than sub...
| Автори: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Опубліковано: |
Elsevier
2016
|
| _version_ | 1826273446382796800 |
|---|---|
| author | Levelt, E Pavlides, M Banerjee, R Mahmod, M Kelly, C Sellwood, J Ariga, R Thomas, S Francis, J Rodgers, C Clarke, W Sabharwal, N Antoniades, C Schneider, J Robson, M Clarke, K Karamitsos, T Rider, O Neubauer, S |
| author_facet | Levelt, E Pavlides, M Banerjee, R Mahmod, M Kelly, C Sellwood, J Ariga, R Thomas, S Francis, J Rodgers, C Clarke, W Sabharwal, N Antoniades, C Schneider, J Robson, M Clarke, K Karamitsos, T Rider, O Neubauer, S |
| author_sort | Levelt, E |
| collection | OXFORD |
| description | <p><b>BACKGROUND</b>- Type 2 diabetes (T2D) and obesity are associated with non-alcoholic fatty liver disease, cardiomyopathy and cardiovascular mortality. Both conditions showed stronger links between ectopic and visceral fat deposition and increased cardio-metabolic risk than subcutaneous fat deposition.</p> <p><b>OBJECTIVES</b>- We tested the hypothesis that even lean patients with T2D (Ln-T2D) exhibit increased ectopic and visceral fat deposition, and that these are linked to cardiac and hepatic changes.</p> <p><b>METHODS</b>- Twenty-seven obese (Ob-T2D), fifteen Ln-T2D with no other comorbidities, and twelve age matched controls were studied. Patients underwent cardiac CT (epicardial fat volume quantification), cardiac MRI (volumes and function), <sup>31</sup>P-MRS (myocardial PCr/ATP), <sup>1</sup>H-MRS (myocardial triglyceride) and multi-parametric liver MRI (<sup>1</sup>H-MRS hepatic triglyceride; T1- and T2*-mapping yielding 'iron-corrected T1' [cT1], a measure of hepatic fibrosis and inflammation). Healthy, lean subjects underwent identical MRI protocols.</p> <p><b>RESULTS</b>- Diabetes, even in the absence of obesity, was associated with increased myocardial triglyceride content (p=0.01), hepatic triglyceride content (p=0.04) and impaired myocardial energetics (p=0.04). While cardiac structural changes, steatosis and energetics were similar between the T2D groups, epicardial fat (p=0.04), hepatic triglyceride (p=0.01) and insulin resistance (p=0.03) were higher in Ob-T2D. Epicardial fat, hepatic triglyceride and insulin resistance correlated negatively with systolic strain and diastolic strain rates which were only significantly impaired in Ob-T2D (p Greater than 0.001 and p=0.006, respectively). Fibroinflammatory liver disease (elevated cT1) was only evident in Ob-T2D (p=0.004 and p Greater than 0.001 vs Ln-T2D and controls, respectively). cT1 correlated with hepatic and epicardial fat (p Greater than 0.001 and p=0.01 respectively).</p> <p><b>CONCLUSIONS</b>- Irrespective of BMI, diabetes is related to significant abnormalities in cardiac structure, energetics, cardiac and hepatic steatosis. Obese patients with T2D show a greater propensity for ectopic and visceral fat deposition that is associated with cardiac dysfunction, fibroinflammatory liver disease and insulin resistance.</p> |
| first_indexed | 2024-03-06T22:28:18Z |
| format | Journal article |
| id | oxford-uuid:576a4a11-fbad-4021-8df3-2f20b7c256d4 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:28:18Z |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:576a4a11-fbad-4021-8df3-2f20b7c256d42022-03-26T16:56:39ZEctopic and visceral fat deposition in lean and obese type 2 diabetes patientsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:576a4a11-fbad-4021-8df3-2f20b7c256d4Symplectic Elements at OxfordElsevier2016Levelt, EPavlides, MBanerjee, RMahmod, MKelly, CSellwood, JAriga, RThomas, SFrancis, JRodgers, CClarke, WSabharwal, NAntoniades, CSchneider, JRobson, MClarke, KKaramitsos, TRider, ONeubauer, S<p><b>BACKGROUND</b>- Type 2 diabetes (T2D) and obesity are associated with non-alcoholic fatty liver disease, cardiomyopathy and cardiovascular mortality. Both conditions showed stronger links between ectopic and visceral fat deposition and increased cardio-metabolic risk than subcutaneous fat deposition.</p> <p><b>OBJECTIVES</b>- We tested the hypothesis that even lean patients with T2D (Ln-T2D) exhibit increased ectopic and visceral fat deposition, and that these are linked to cardiac and hepatic changes.</p> <p><b>METHODS</b>- Twenty-seven obese (Ob-T2D), fifteen Ln-T2D with no other comorbidities, and twelve age matched controls were studied. Patients underwent cardiac CT (epicardial fat volume quantification), cardiac MRI (volumes and function), <sup>31</sup>P-MRS (myocardial PCr/ATP), <sup>1</sup>H-MRS (myocardial triglyceride) and multi-parametric liver MRI (<sup>1</sup>H-MRS hepatic triglyceride; T1- and T2*-mapping yielding 'iron-corrected T1' [cT1], a measure of hepatic fibrosis and inflammation). Healthy, lean subjects underwent identical MRI protocols.</p> <p><b>RESULTS</b>- Diabetes, even in the absence of obesity, was associated with increased myocardial triglyceride content (p=0.01), hepatic triglyceride content (p=0.04) and impaired myocardial energetics (p=0.04). While cardiac structural changes, steatosis and energetics were similar between the T2D groups, epicardial fat (p=0.04), hepatic triglyceride (p=0.01) and insulin resistance (p=0.03) were higher in Ob-T2D. Epicardial fat, hepatic triglyceride and insulin resistance correlated negatively with systolic strain and diastolic strain rates which were only significantly impaired in Ob-T2D (p Greater than 0.001 and p=0.006, respectively). Fibroinflammatory liver disease (elevated cT1) was only evident in Ob-T2D (p=0.004 and p Greater than 0.001 vs Ln-T2D and controls, respectively). cT1 correlated with hepatic and epicardial fat (p Greater than 0.001 and p=0.01 respectively).</p> <p><b>CONCLUSIONS</b>- Irrespective of BMI, diabetes is related to significant abnormalities in cardiac structure, energetics, cardiac and hepatic steatosis. Obese patients with T2D show a greater propensity for ectopic and visceral fat deposition that is associated with cardiac dysfunction, fibroinflammatory liver disease and insulin resistance.</p> |
| spellingShingle | Levelt, E Pavlides, M Banerjee, R Mahmod, M Kelly, C Sellwood, J Ariga, R Thomas, S Francis, J Rodgers, C Clarke, W Sabharwal, N Antoniades, C Schneider, J Robson, M Clarke, K Karamitsos, T Rider, O Neubauer, S Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| title | Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| title_full | Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| title_fullStr | Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| title_full_unstemmed | Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| title_short | Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| title_sort | ectopic and visceral fat deposition in lean and obese type 2 diabetes patients |
| work_keys_str_mv | AT levelte ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT pavlidesm ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT banerjeer ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT mahmodm ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT kellyc ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT sellwoodj ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT arigar ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT thomass ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT francisj ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT rodgersc ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT clarkew ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT sabharwaln ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT antoniadesc ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT schneiderj ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT robsonm ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT clarkek ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT karamitsost ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT ridero ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients AT neubauers ectopicandvisceralfatdepositioninleanandobesetype2diabetespatients |